Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 368

1.

GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.

Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC.

J Neuroimmunol. 2015 Apr 15;281:73-7. doi: 10.1016/j.jneuroim.2015.03.009. Epub 2015 Mar 10.

PMID:
25867471
2.

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Chin RL, Deng C, Bril V, Hartung HP, Merkies IS, Donofrio PD, van Doorn PA, Dalakas MC, Latov N.

Muscle Nerve. 2015 Feb 27. doi: 10.1002/mus.24624. [Epub ahead of print]

PMID:
25728021
3.

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.

Stathopoulos P, Alexopoulos H, Dalakas MC.

Nat Rev Neurol. 2015 Mar;11(3):143-156. doi: 10.1038/nrneurol.2014.260. Epub 2015 Jan 27. Review.

PMID:
25623793
4.

Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Lünemann JD, Nimmerjahn F, Dalakas MC.

Nat Rev Neurol. 2015 Feb;11(2):80-9. doi: 10.1038/nrneurol.2014.253. Epub 2015 Jan 6. Review.

PMID:
25561275
5.

7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Dalakas MC, Löscher WN.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:138. doi: 10.1111/cei.12544.

PMID:
25546795
6.

7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Dalakas MC, Löscher WN.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:124-6. doi: 10.1111/cei.12538.

PMID:
25546789
7.

Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression.

Alexopoulos H, Dagklis IE, Akrivou S, Bostantjopoulou S, Dalakas MC.

Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e39. doi: 10.1212/NXI.0000000000000039. eCollection 2014 Dec. No abstract available.

8.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.

Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2014 Dec 15;347(1-2):143-7. doi: 10.1016/j.jns.2014.09.035. Epub 2014 Sep 28.

PMID:
25304055
9.

Reliability of the adult myopathy assessment tool in individuals with myositis.

Harris-Love MO, Joe G, Davenport TE, Koziol D, Abbett Rose K, Shrader JA, Vasconcelos OM, McElroy B, Dalakas MC.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):563-70. doi: 10.1002/acr.22473.

PMID:
25201624
10.

Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.

Markakis I, Alexopoulos H, Poulopoulou C, Akrivou S, Papathanasiou A, Katsiva V, Lyrakos G, Gekas G, Dalakas MC.

J Neurol Sci. 2014 Aug 15;343(1-2):192-4. doi: 10.1016/j.jns.2014.05.032. Epub 2014 May 27.

PMID:
24950904
11.

Pathogenesis of immune-mediated neuropathies.

Dalakas MC.

Biochim Biophys Acta. 2015 Apr;1852(4):658-666. doi: 10.1016/j.bbadis.2014.06.013. Epub 2014 Jun 17. Review.

PMID:
24949885
12.

Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.

Dalakas MC.

J Clin Immunol. 2014 Jul;34 Suppl 1:S120-6. doi: 10.1007/s10875-014-0024-5. Epub 2014 Apr 11. Review.

PMID:
24722854
13.

IVIg in the chronic management of myasthenia gravis: is it enough for your money?

Dalakas MC.

J Neurol Sci. 2014 Mar 15;338(1-2):1-2. doi: 10.1016/j.jns.2013.12.034. Epub 2013 Dec 27. No abstract available.

PMID:
24411405
14.

Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.

Alexopoulos H, Akrivou S, Dalakas MC.

Neurology. 2013 Nov 26;81(22):1962-4. doi: 10.1212/01.wnl.0000436617.40779.65. Epub 2013 Oct 30. No abstract available.

PMID:
24174585
15.

Immunology of stiff person syndrome and other GAD-associated neurological disorders.

Alexopoulos H, Dalakas MC.

Expert Rev Clin Immunol. 2013 Nov;9(11):1043-53. doi: 10.1586/1744666X.2013.845527. Review.

PMID:
24168411
16.

Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives.

Schmidt J, Dalakas MC.

Expert Rev Clin Immunol. 2013 Nov;9(11):1125-33. doi: 10.1586/1744666X.2013.842467. Epub 2013 Oct 21. Review.

PMID:
24138579
17.

The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study.

Kosmidis ML, Alexopoulos H, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2013 Nov 15;334(1-2):123-5. doi: 10.1016/j.jns.2013.08.007. Epub 2013 Aug 14.

PMID:
23998706
18.

Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.

Alexopoulos H, Kampylafka EI, Chatzi I, Travasarou M, Karageorgiou KE, Dalakas MC, Tzioufas AG.

J Neuroimmunol. 2013 Jul 15;260(1-2):117-20. doi: 10.1016/j.jneuroim.2013.04.017. Epub 2013 May 11.

PMID:
23673145
19.

Pathophysiology of autoimmune polyneuropathies.

Dalakas MC.

Presse Med. 2013 Jun;42(6 Pt 2):e181-92. doi: 10.1016/j.lpm.2013.01.058. Epub 2013 Apr 30. Review.

PMID:
23642299
20.

Novel future therapeutic options in myasthenia gravis.

Dalakas MC.

Autoimmun Rev. 2013 Jul;12(9):936-41. doi: 10.1016/j.autrev.2013.03.006. Epub 2013 Mar 26. Review.

PMID:
23537505
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk